IRIS
AMODIO, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 732
NA - Nord America 596
EU - Europa 283
SA - Sud America 190
AF - Africa 42
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 569
SG - Singapore 265
VN - Vietnam 163
CN - Cina 134
BR - Brasile 128
IT - Italia 79
HK - Hong Kong 50
DE - Germania 44
FR - Francia 42
AR - Argentina 23
AT - Austria 23
FI - Finlandia 14
IQ - Iraq 14
GB - Regno Unito 13
IN - India 13
KR - Corea 13
UA - Ucraina 13
BD - Bangladesh 12
MX - Messico 11
CA - Canada 10
CO - Colombia 10
SN - Senegal 9
PK - Pakistan 8
RU - Federazione Russa 8
ZA - Sudafrica 8
DZ - Algeria 7
SE - Svezia 7
TR - Turchia 7
CL - Cile 6
EC - Ecuador 6
ES - Italia 6
PY - Paraguay 6
ID - Indonesia 5
NL - Olanda 5
PL - Polonia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
EG - Egitto 4
PH - Filippine 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BE - Belgio 3
BG - Bulgaria 3
JP - Giappone 3
KG - Kirghizistan 3
MA - Marocco 3
NP - Nepal 3
TN - Tunisia 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
SC - Seychelles 2
TG - Togo 2
TH - Thailandia 2
UY - Uruguay 2
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IE - Irlanda 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PF - Polinesia Francese 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.848
Salva come PNG Salva come JPEG
Città #
Dallas 220
Singapore 128
San Jose 67
Ho Chi Minh City 50
Hong Kong 49
Hanoi 45
Ashburn 43
Beijing 37
Chandler 35
Lauterbourg 23
New York 16
Boardman 14
Helsinki 14
Los Angeles 14
Vienna 14
Seoul 13
Da Nang 11
Rende 11
Munich 10
Dakar 9
Florence 9
Hefei 9
Shanghai 9
São Paulo 9
Guangzhou 7
Haiphong 7
San Mateo 7
Baghdad 6
Buenos Aires 6
Council Bluffs 6
Frankfurt am Main 6
Santa Clara 6
Biên Hòa 5
Jacksonville 5
Medellín 5
Rio de Janeiro 5
São José do Rio Preto 5
Tashkent 5
Bremen 4
Duhok 4
Elk Grove Village 4
Falkenstein 4
Goiânia 4
Lawrence 4
Mexico City 4
Montreal 4
Riyadh 4
Warsaw 4
Acerra 3
Brescia 3
Brussels 3
Caracas 3
Catania 3
Curitiba 3
Dearborn 3
Fortaleza 3
Izmir 3
Mauá 3
Mosul 3
Noida 3
Ogden 3
Orem 3
Phoenix 3
Recife 3
Redwood City 3
Roxbury 3
Salvador 3
Secaucus 3
Uberlândia 3
Wuhan 3
Abu Dhabi 2
Amman 2
Amsterdam 2
Asunción 2
Aversa 2
Baku 2
Bandar Seri Begawan 2
Bishkek 2
Borgomanero 2
Boston 2
Cairo 2
Cape Town 2
Casablanca 2
Charlotte 2
Chennai 2
Chicago 2
Cochabamba 2
Cosenza 2
Dhaka 2
Formosa 2
Giza 2
Guarapari 2
Guarulhos 2
Hangzhou 2
Hillsboro 2
Inglewood 2
Islamabad 2
Istanbul 2
Johannesburg 2
Lomé 2
Totale 1.106
Salva come PNG Salva come JPEG
Nome #
Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options? 161
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 150
First evidence on the novel hypothalamic peptide Phoenixin-14 as cardiac modulator and cardioprotective in normal and obese rats 138
Current Status and Future Perspectives on Therapeutic Potential of Apigenin: Focus on Metabolic-Syndrome-Dependent Organ Dysfunction 135
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma 119
Epigenetic regulation of mitochondrial quality control genes in multiple myeloma: A sequenom massarray pilot investigation on hmcls 105
Vaccination in Multiple Myeloma: Challenges and Strategies 96
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax 93
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 83
Rilzabrutinib for the Treatment of Immune Thrombocytopenia 78
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 74
Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma 72
Maintenance therapy after ASCT in newly diagnosed multiple myeloma patients: single agent versus combination drugs 68
A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients 64
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" Questions 57
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents 48
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real‐World Study 34
Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and Immunization 34
Real‐World Evaluation of Oral Decitabine/Cedazuridine in Elderly Patients With Acute Myeloid Leukemia 30
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapy 23
OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development 22
The Non-Coding RNA Journal Club: Highlights on Recent Papers-14 21
Chemotherapy‐Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune‐Based Approaches 20
Beyond PD‐1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next‐Generation Immune Strategies 20
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies 18
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 15
Management of Primary Refractory Diffuse Large B‐Cell Lymphoma in Patients Unsuitable for CAR T‐Cell Therapy 15
Targeting the Menin– KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical Translation 14
Comparative efficacy of different therapeutic approaches in treatment naïve FLT3-mutated AML eligible for intensive chemotherapy: a Bayesian network meta-analysis of randomized trials 14
Relapse Despite MRD Negativity in Multiple Myeloma: Toward Integrated Risk Prediction 13
Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities 13
Reshaping multiple myeloma treatment: recent breakthroughs 13
Frontline Therapy in Diffuse Large B‐Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions 12
Ph‐Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet Needs 11
Targeting Ikaros and Aiolos: Next‐Generation Cereblon E3 Ligase Modulators in MM 10
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration 9
Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging Perspectives 7
Totale 1.909
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 0 1
2021/202246 0 3 1 5 2 1 1 14 1 2 5 11
2022/202391 10 12 3 12 14 5 2 10 14 1 5 3
2023/202494 11 5 8 10 2 17 9 1 5 5 10 11
2024/2025184 11 15 5 11 3 5 5 7 26 24 12 60
2025/20261.459 64 114 227 120 207 134 127 92 168 206 0 0
Totale 1.909